LP(a) phenotypes and levels in angiographically proven coronary heart disease patients and controls

Indian Journal of Clinical Biochemistry

Volumn 13, Issue 1, 1998, Pages 12-19

  Luthra, Kalpana ^a   Vasisht, Suman ^a   Chhabra, Shivani ^a   Raju, K R ^a   Agarwal, D P ^b   Manchanda, S C ^a   Srivastava, L M ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Apolipoprotein(a); Cholesterol; Coronary artery disease; Lipoprotein(a)

Indexed keywords

EID: 0041195392     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02873437     Document Type: Article

References (21)

1. Utermann, G. (1994) Lipoprotein (a). The metabolic and molecular basis of inherited disease, Eds. C. R. Scriver, A. L. Beaudet, W. S. Sly, J. B. Stanbury, J. B. Wyngarden, D. S. Fredrickson, McGrawHill Inc, New York, p. 1887-1912.
2. Boerwinkle, E., Leffert, C. C., Lin. J., Lackner, C., Chiesa, G. and Hobbs, H. H. (1992) Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J. Clin. Invest. 90, 52-60.
3. Brewer, H. B. Jr (1992) Effectiveness of diets and drugs in the treatment of patients with elevated Lp(a) levels. In: Lipoprotein(a), Ed. A. M. Scanu, Academic Press Inc, P. 211-220.
4. Kemmler, H. G. and Seitz, C. (1987) Lp(a) glycoprotein phenotypes: inheritance and relation to LP(a)-lipoprotein. J. CIin. lnvest. 80, 458-465.
5. Lackner, C, Boerwinkle, E., Leffert, C. C., Rahjnig, T. and Hobbs, H. H. (1991) Molecular basis of apoliproprotein (a) isoform heterogeneity as resolved by pulsed-field gel electrophoresis. J. Clin. Invest. 87, 2153-2161.
6. Smith, E. B. and Cochran, S. (1990) Factors influencing the accumulation in fibrous plaques of lipid, derived from low-density lipoproteins: preferential immobilization of Lp(a). Atherosclerosis 84, 173- 181.
7. Graininger, D. J., Kirchenloke, H. L., Metcalfe, J. C., Weissberg, P. L., Wade, D. P. and Lawn, R. M. (1993) Proliferation of human smooth muscle cells promoted by LP(a). Science 260, 1655-1658.
8. Kostner, G. M. (1988) Interaction of LP(a) and LDL with glycosaminoglycans and proteoglycans from human aorta. Arteriorscelerosis 8, 851-857.
9. Salonen, E. M., Jauhianen, M., Zardil, F., Vohevi, A. and Ehnholm, C. (1984) LP(a) binds to fibronectin and has serine protease activity, capable of cleaving it. EMBO J. 8, 4035-4040.
10. Miles, LA. and Plow, E. F. (1990) LP(a): an interloper into the fibrinolytic system? Thromb. and Haemostatasis 63(3), 331-335.
11. Gotoh, T., Kuroda, T., Yamasawa, M., Nishinaga, M., Yamada, S., Matsuo, H., Hosoe, M., Itoh, Y., Kawai, T., Igarashi, M. and Shimada, K. (1995) Correlation between lipoprotein (a) and aortic valve sclerosis assessed by echocardiography (the JMS cardiac echo and whort study). Amer. J. Cardiology 76, 928-932.
12. Schaefer, E. J., Lamon-Fava. S., Jenner. J. L., McNamara. J. R., Ordovas, J. M., Lippel. K. and Levy, R. I. (1994) Lipoprotein (a) levels and risk of coronary heart disease in men. J. Amer. Med. Assoc. 271, 999-1003.
13. Utermann, G. (1989) The mysteries of lipoprotein (a). Science 246, 904-910.
14. Moliterno, D. J., Jokinen, E. V., Miserez, A. R. Lange, R. A., Willard, J. E., Boerwinkle, E., Hillis, D. and Hobbs, H. H. (1995) No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler. Thromb. Vase. Biol. 15, 850-855.
15. Kronenberg, F., Lobentanz, E. M., Konig, P., Utermann, G. and Dieplinger, H. (1994) Effect of sample storage on the measurement of lipoprotein (a), apolipoprotein B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J. Lipid Res. 35, 1318-1328.
16. Kamboh, M. I., Ferrell, R. E., Kottke, B. A. (1991) Expressed hypervariable polymorphism of apolipoprotein(a). Amer. J. Hum. Genet. 49, 1063-1074.
17. Amemiya, H., Arinami. T., Kikuchi. S., Yamakawa-Kobayashi. K, Li, L., Fujiwara. H., Hiroe. M., Marumo. F. and Hamaguchi. H. (1996) Apolipoprotein(a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease. Arteriorscelrosis 123, 181-191.
18. Ridker, P. M., Hennekens, C. H. and Stampfer, M. J. (1993) A prospective study of lipoprotein(a) and the risk of myocardial infarction. J. Amer. Med. Assoc. 270, 2195-2199.
19. Alfthan, G., Pekkanen, J., Jauhianen, M., Pitkaniemi, K. M., Toumiletho. J. Salonen, J. T. and Ehnholm, C. (1994) Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 106, 9-19.
20. Klausen, I. C., Beisiegel, U., Menzel, M. J., Rosseneu, M., Nicaud, V. and Faergeman, O. (1995) Apo(a) phenotypes and LP(a) concentrations in offspring of men with and without myocardial infarction. The EARS study. Arterioscler. Thromb. Vasc. Biol. 15, 1001-1008.
21. Kraft, H. G., Lingenhel. A., Pang. R. W. C., Delport. R., Trommsdorff. M., Vermaak. H., Janus. E. D. and Utermann. G. (1996) Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on Lipoprotein(a) levels in Caucasian, Asian and African populations: The distribution of Null alleles is non-random. Eur. J. Hum. Genet. 4, 74-87.